The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Today, Benzinga 's options scanner spotted 10 uncommon options trades for Abbott Laboratories. This isn't normal. The overall ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

The Texas Senate passed the hemp ban backed by Lt. Gov. Dan Patrick. If passed by the House, SB 3 would ban nearly all forms ...

Abbott, a manufacturer of diagnostics and medical devices, sent a film crew to highlight Auburn Community Hospital's ...

Abbott has been investing in structural heart products and recently entered the fast-growing left atrial appendage closure market. Despite falling behind in the race for pulsed field ablation ...

ABT's shares rise on the back of its diversified business portfolio. However, the unfavorable macroeconomic scenario is concerning.

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Texas legislature reverses course on THC ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best ...

The U.S. Food and Drug Administration (FDA) is stepping up testing for heavy metals in infant formula and reviewing key ...